Set202 is a histone lysine methyltransferase that enables Cryptococcus neoformans to adapt to the host environment

Avatar
Presentation is building ... The process may take up to 3 minutes. If the page does not reload automatically, please reload it manually.
Voice is AI-generated
Connected to paperThis paper is a preprint and has not been certified by peer review

Set202 is a histone lysine methyltransferase that enables Cryptococcus neoformans to adapt to the host environment

Authors

Agyei, G.; Anderson, K. C.; Stuckey, P. V.; Celis, F. J.; Theisen, T. J.; Santiago-Tirado, F. H.

Abstract

All pathogens rely on dynamic gene expression for host adaptation and disease causation. This is especially important for pathogens that normally are found in the environment, like Cryptococcus neoformans, given that environmental and host conditions are dramatically different. Epigenetic modifications, like those carried out by SET-domain histone lysine methyltransferases (HKMTs), are essential for this genome expression flexibility. While transcription factors and signaling cascades have been well-studied in C. neoformanss host adaptation, the role of HKMTs in this process has not been explored. Here, we characterize the gene SET202, previously reported as a putative HKMT important for growth in host lungs. We show that set202{Delta} mutants have 50% less phagosomal permeabilization than the wild-type fungi, have phagosomal maturation defects, and poor intracellular survival. Additionally, they are defective in traits promoting virulence, including significantly smaller capsules, less melanin, and poor growth under host-like conditions. These phenotypes contributed to reduced virulence in a murine model of infection but, notably, this defect was host-temperature-dependent. In order to explain mechanistically how SET202 deletion could affect such a wide range of processes, we assessed and demonstrated, for the first time, that Set202 is a true histone-3-lysine 36 methyltransferase, supporting its role in epigenetically modifying the fungal genome to enable adaptation to the hostile host conditions. Consequently, our findings support the study of the biological function of Set202, as it can serve as a potential future therapeutic target for the treatment of infections caused by C. neoformans, and possibly other pathogenic fungi.

Follow Us on

0 comments

Add comment